EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rapid iPSC inclusionopathy models shed light on formation, consequence, and molecular subtype of α-synuclein inclusions

Isabel Lam, Alain Ndayisaba, Amanda J Lewis, YuHong Fu, Giselle T Sagredo, Anastasia Kuzkina, Ludovica Zaccagnini, Meral Celikag, Jackson Sandoe, Ricardo L Sanz, Aazam Vahdatshoar, Timothy D Martin und 42 weitere

Neuron · 2024-09 · 112 (17) · 2886-2909.e16

DOI: 10.1016/j.neuron.2024.06.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuron, 2024-09. Verfasst von Isabel Lam und 53 weiteren Autor:innen. Beteiligte Einrichtung: Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA; Division of Movement Disorders, American Parkinson Disease …. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, alpha-Synuclein, Inclusion Bodies. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NIGMS NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The heterogeneity of protein-rich inclusions and its significance in neurodegeneration is poorly understood. Standard patient-derived iPSC models develop inclusions neither reproducibly nor in a reasonable time frame. Here, we developed screenable iPSC "inclusionopathy" models utilizing piggyBac or targeted transgenes to rapidly induce CNS cells that express aggregation-prone proteins at brain-like levels. Inclusions and their effects on cell survival were trackable at single-inclusion resolution. Exemplar cortical neuron α-synuclein inclusionopathy models were engineered through transgenic expression of α-synuclein mutant forms or exogenous seeding with fibrils. We identified multiple inclusion classes, including neuroprotective p62-positive inclusions versus dynamic and neurotoxic lipid-rich inclusions, both identified in patient brains. Fusion events between these inclusion subtypes altered neuronal survival. Proteome-scale α-synuclein genetic- and physical-interaction screens pinpointed candidate RNA-processing and actin-cytoskeleton-modulator proteins like RhoA whose sequestration into inclusions could enhance toxicity. These tractable CNS models should prove useful in functional genomic analysis and drug development for proteinopathies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Induced Pluripotent Stem Cellsalpha-SynucleinInclusion BodiesHumansSynucleinopathiesNeuronsBrain

Stichwörter der Autor:innen

CRISPR screenLewy bodyParkinson’s diseaseRab proteinRhoAactin cytoskeletonaggregationdementia with Lewy bodiesgliaiPSCinclusionlipidneurodegenerationneuronp62

Substanzen

alpha-Synuclein

Autor:innen und Institutionen

  • Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA; Division of Movement Disorders, American Parkinson Disease Association (APDA) Center for Advanced Research and MSA Center of Exce…
  • École Polytechnique Fédérale de Lausanne and University of Lausanne, Lausanne, Switzerland.
  • The University of Sydney Brain and Mind Centre and Faculty of Medicine and Health School of Medical Science, Sydney, NSW, Australia.
  • Dementia Research Institute, University College London, London, UK.
  • Whitehead Institute for Biomedical Research, Cambridge, MA, USA.
  • Harvard Medical School, Boston, MA, USA; Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA; Howard Hughes Medical Institute, Chevy Chase, MD, USA.

Förderung

  • NINDS NIH HHS
  • NIGMS NIH HHS
  • NIA NIH HHS
  • National Institutes of Health
  • National Health and Medical Research Council
  • Michael J Fox Foundation for Parkinson's Research
  • Brigham Research Institute
  • American Academy of Neurology

Zitieren

APA

Lam, I., Ndayisaba, A., Lewis, A. J., Fu, Y., Sagredo, G. T., Kuzkina, A., Zaccagnini, L., Celikag, M., Sandoe, J., Sanz, R. L., Vahdatshoar, A., Martin, T. D., Morshed, N., Ichihashi, T., Tripathi, A., Ramalingam, N., Oettgen-Suazo, C., Bartels, T., Boussouf, M., …, & Khurana, V. (2024). Rapid iPSC inclusionopathy models shed light on formation, consequence, and molecular subtype of α-synuclein inclusions. Neuron, 112(17), 2886-2909.e16. https://doi.org/10.1016/j.neuron.2024.06.002

Vancouver

Lam I, Ndayisaba A, Lewis AJ, Fu Y, Sagredo GT, Kuzkina A, et al. Rapid iPSC inclusionopathy models shed light on formation, consequence, and molecular subtype of α-synuclein inclusions. Neuron. 2024;112(17):2886-2909.e16. doi:10.1016/j.neuron.2024.06.002

BibTeX
@article{Lam2024,
  author = {Lam, Isabel and Ndayisaba, Alain and Lewis, Amanda J and Fu, YuHong and Sagredo, Giselle T and Kuzkina, Anastasia and Zaccagnini, Ludovica and Celikag, Meral and Sandoe, Jackson and Sanz, Ricardo L and Vahdatshoar, Aazam and Martin, Timothy D and Morshed, Nader and Ichihashi, Toru and Tripathi, Arati and Ramalingam, Nagendran and Oettgen-Suazo, Charlotte and Bartels, Theresa and Boussouf, Manel and Schäbinger, Max and Hallacli, Erinc and Jiang, Xin and Verma, Amrita and Tea, Challana and Wang, Zichen and Hakozaki, Hiroyuki and Yu, Xiao and Hyles, Kelly and Park, Chansaem and Wang, Xinyuan and Theunissen, Thorold W and Wang, Haoyi and Jaenisch, Rudolf and Lindquist, Susan and Stevens, Beth and Stefanova, Nadia and Wenning, Gregor and van de Berg, Wilma D J and Luk, Kelvin C and Sanchez-Pernaute, Rosario and Gómez-Esteban, Juan Carlos and Felsky, Daniel and Kiyota, Yasujiro and Sahni, Nidhi and Yi, S Stephen and Chung, Chee Yeun and Stahlberg, Henning and Ferrer, Isidro and Schöneberg, Johannes and Elledge, Stephen J and Dettmer, Ulf and Halliday, Glenda M and Bartels, Tim and Khurana, Vikram},
  title = {Rapid iPSC inclusionopathy models shed light on formation, consequence, and molecular subtype of α-synuclein inclusions},
  journal = {Neuron},
  year = {2024},
  volume = {112},
  number = {17},
  pages = {2886--2909.e16},
  doi = {10.1016/j.neuron.2024.06.002}
}
Kostenlos starten →